Management expects completion of VISTAS study enrollment for Volixibat in PSC in the third quarter of 2025, with data readout ...
Looking back at the 14th Five-Year Plan period, the company anchored in the goal of high-quality development, bringing operating performance to a new level. All of the compound annual growth rates of ...
FY 2025 Revenue up 542% to $5.6 Million; Positive Operating Income of $1.3 Million and Net Income of $1.1 Million ...
WILMINGTON, DE – March 30, 2026 – PRESSADVANTAGE – ...
To scale efficiently while maintaining high service standards, many institutions are adopting a more flexible operating model ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results